Recruiting

Autologous Secretome

Sponsor:

Acorn Biolabs Inc.

Code:

NCT06477172

Conditions

Post Procedural Erythema

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Study Details

Brief summary:

Non-interventional, multi-site, prospective, open-label, observational, real-world study of autologous hair follicle secretome use.

Conditions

Post Procedural Erythema

Study ID

NCT06477172

Start date

Sep 9, 2024

Status verified date

Mar, 2026

Completion date

Feb, 2027

Anticipated

Primary completion date

Feb, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Male and Female
  • Ages: 18-60
  • Any Fitzpatrick skin type
  • Planning a medical aesthetic procedure
  • For subjects receiving hair procedures (closed to enrollment):

1. Androgenic alopecia
2. Traction alopecia
3. Scarring alopecia
4. Stable use of any medication or supplement for hair loss, including finasteride, any other 5 α-reductase inhibitor, minoxidil, steroids, or hormonal products, during the 3 months prior to enrollment in the study is allowed.
5. No intention to start new hair growth medications or change dose of hair growth medications from the time of consent through the end of the study follow-up period.
  • Undergoing one of the following medical aesthetic procedures:

1. Laser resurfacing of the face (ablative or non-ablative) or Ellacor of the face (Ellacor closed to enrollment)
2. Tixel of the face
3. Keralase of the scalp (scalp treatment closed to enrollment)
4. Acne Scars and Surgery scars, either old or new as long as old scars are also being treated with ablative or non-ablative laser or microneedling (e.g. abdominoplasty, breast reduction/ reconstruction/enhancement, post-weight loss, etc.
  • Planning to use Acorn Autologous Hair Follicle Secretome cosmetic product

Exclusion Criteria:

  • Pregnant or Breastfeeding
  • Participation in an interventional clinical trial in the last 30 days
  • Use of other topical cosmetic products that may confound results
  • Use of retinoids within 7 days prior to facial procedure
  • For those receiving hair treatment, must not have had a hair transplant in the treatment area within the past 12 months
  • Any health condition that in the investigator's opinion should preclude participation in study

Study Design

Enrollment

500 participants

Anticipated

Interventions and Outcome Measures

Primary outcome measure

  • Post-Procedure Symptoms [ Time Frame: 1-7 days ]
  • Downtime Questionnaire [ Time Frame: 1-7 days ]

Central Contacts and Locations

Central contacts

Locations

BelleSante

Recruiting

Scottsdale, Arizona, United States, 85260

Contacts

Principal Investigator:

Kristine Romine, MD, FAAD

Behr Laser & Skin Care Center

Recruiting

Fresno, California, United States, 93720

Contacts

Principal Investigator:

Kathleen Behr, MD

Aesthetics By Dr. Lee

Recruiting

Granite Bay, California, United States, 95746

Contacts

Principal Investigator:

Luis Lee, MD

Carlo Honrado, MD, FACS

Recruiting

Los Angeles, California, United States, 90067

Contacts

Principal Investigator:

Carlo Honrado, MD, FACS

N2 Aesthetics

Recruiting

Manhattan Beach, California, United States, 90266

Contacts

Principal Investigator:

Nicola Lowrey, MPAP PA-C

Marina Plastic Surgery

Recruiting

Marina del Rey, California, United States, 90292

Principal Investigator:

Justin Perez, MD

M Beauty by Tess

Recruiting

San Diego, California, United States, 92126

Contacts

Principal Investigator:

Tess Mauricio, MD

Ziering Medical

Recruiting

West Hollywood, California, United States, 90069

Contacts

Principal Investigator:

Craig L. Ziering, DO FAOCD FISHRS

Bauman Medical

Recruiting

Boca Raton, Florida, United States, 33432

Contacts

Principal Investigator:

Alan J. Bauman, MD

Mirror Plastic Surgery

Recruiting

St. Petersburg, Florida, United States, 33701

Contacts

Principal Investigator:

Akash Chandawarkar, MD

Hive Aesthetic LLC

Recruiting

Chicago, Illinois, United States, 60657

Contacts

Principal Investigator:

Christopher Rosenbarger, PA-C

Chernoff Cosmetic Surgery

Recruiting

Indianapolis, Indiana, United States, 46220

Contacts

Principal Investigator:

Gregory Chernoff, MD

AIEREM Aesthetics Spa & Plastic Surgery

Recruiting

Manhattan, New York, United States, 75231

Contacts

Principal Investigator:

Eunice Park, MD

Lewis Dermatology and Associates

Recruiting

New York, New York, United States, 10021

Principal Investigator:

Amy Lewis, MD

AIEREM Aesthetics Spa & Plastic Surgery

Recruiting

Syosset, New York, United States, 11791

Contacts

Principal Investigator:

Eunice Park, MD

Austin Plastic Surgeon

Recruiting

Austin, Texas, United States, 78758

Contacts

Principal Investigator:

Johnny Franco, MD

Dallas Plastic Surgery Institute

Recruiting

Dallas, Texas, United States, 75225

Contacts

Principal Investigator:

David Weir, MSN, APRN, NP-C

US Dermatology Partners / Dermatology Associates of Tyler

Recruiting

Tyler, Texas, United States, 75703

Principal Investigator:

Jennifer D Holman, MD

AG Aesthetic Centre

Recruiting

Vancouver, Washington, United States, 98660

Contacts

Principal Investigator:

Allen Gabriel, MD

Dr. Jean Carruthers Cosmedic

Recruiting

Vancouver, British Columbia, Canada, V5Z 4E1

Contacts

Principal Investigator:

Jean Carruthers, MD, FRCSC, FRC (OPHTH)

Dr. Amber Bocknek

Recruiting

Aurora, Ontario, Canada, L4G1B9

Contacts

Amber Bocknek, MD

amberbocknek@gmail.com

Principal Investigator:

Amber Bocknek, MD

Rejuuv

Recruiting

Toronto, Ontario, Canada, M5R 0C7

Contacts

Principal Investigator:

Shawn Seit, MD

Dr. Nowell Solish Cosmetic Dermatologist

Recruiting

Toronto, Ontario, Canada, M5R 3N8

Contacts

Principal Investigator:

Nowell Solish, MD

Clinique Antiaging

Recruiting

Montreal, Quebec, Canada, H3A 1S2

Contacts

Principal Investigator:

Cynthia Stolovitz, MD

More Information

Sponsor

Acorn Biolabs Inc.

Last update posted

Mar 4, 2026

Last verified

Mar, 2026

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-08. This information was provided to ClinicalTrials.gov by Acorn Biolabs Inc. on 2026-03-04.